KLRS
Invesco’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,912
| Closed | -$8.99K | – | 3973 |
|
|
2024
Q1 | $8.99K | Hold |
11,912
| – | – | ﹤0.01% | 3838 |
|
|
2023
Q4 | $8.1K | Buy |
11,912
+387
| +3% | +$263 | ﹤0.01% | 3810 |
|
|
2023
Q3 | $24.8K | Buy |
11,525
+841
| +8% | +$1.81K | ﹤0.01% | 3834 |
|
|
2023
Q2 | $36.3K | Sell |
10,684
-1,083
| -9% | -$3.68K | ﹤0.01% | 3819 |
|
|
2023
Q1 | $46.4K | Sell |
11,767
-786
| -6% | -$3.1K | ﹤0.01% | 3745 |
|
|
2022
Q4 | $64.4K | Sell |
12,553
-172,278
| -93% | -$884K | ﹤0.01% | 3866 |
|
|
2022
Q3 | $1.46M | Buy |
184,831
+172,665
| +1,419% | +$1.36M | ﹤0.01% | 2758 |
|
|
2022
Q2 | $48K | Sell |
12,166
-2,470
| -17% | -$9.75K | ﹤0.01% | 3944 |
|
|
2022
Q1 | $99K | Buy |
14,636
+132
| +0.9% | +$893 | ﹤0.01% | 3832 |
|
|
2021
Q4 | $187K | Sell |
14,504
-1,877
| -11% | -$24.2K | ﹤0.01% | 3760 |
|
|
2021
Q3 | $410K | Buy |
16,381
+1,890
| +13% | +$47.3K | ﹤0.01% | 3483 |
|
|
2021
Q2 | $286K | Buy |
+14,491
| New | +$286K | ﹤0.01% | 3619 |
|